A study of patients' choice of medical treatment based on rational choice theory: a cross-sectional survey from China
Family Practice · 2024
DOI: 10.1093/fampra/cmae039 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Family Practice, 2024. Verfasst von Jin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Office, Shenzhen Traditional Chinese Medicine Hospital, Guangdong, 518033, China. Hauptthemen laut MEDLINE: Choice Behavior, Primary Health Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To describe how patients choose between primary care institutions (PCIs) and non-PCIs using rational choice theory from the perspective of survival rationality, economic rationality, and social rationality.
Methods
Multi-stage stratified sampling and convenience sampling were applied to select 1723 patients to conduct the questionnaire survey. Chi-square test and binary logistic regression were performed to analyze the factors associated with patients’ choice of PCIs.
Results
In total 55.83% of 1723 patients would attend a PCIs for healthcare. The results of the univariate analysis revealed that patients who are female (58.46%, P = .015), suffering from chronic diseases (56.26%, P = .047), inpatients (67.58%, P < .001), Beijing (59.62%, P = .002), partial understanding of the family doctor contracting system (62.30%, P < .001), and not understanding of the medical alliance policy (58.04%, P = .031) had significantly higher probability of choosing PCIs. Logistic regression analysis showed that females were more unwilling to attend PCIs (odds ratio (OR) = 0.822, 95%CI: 0.676–0.999). Following survival rationality, patients without chronic diseases were more likely to attend PCIs (OR = 1.834, 95%CI: 1.029–3.268), and inpatients were more unlikely to attend PCIs (OR = 0.581, 95%CI: 0.437–0.774). From an economic rationality perspective, patients from the Fujian province were more likely to attend PCIs (OR = 1.424, 95%CI: 1.081–1.876). From a social rationality perspective, patients who partial understanding of the family doctor contracting system were more unlikely to attend PCIs (OR = 0.701, 95%CI: 0.551–0.892), and patients who partial and complete understanding of the medical alliance policy were more likely to attend PCIs (OR = 1.340, 95%CI: 1.064–1.687; OR = 1.485, 95%CI: 1.086–2.030).
Conclusions
Survival, economic, and social rationality are involved in patients’ choice to attend PCIs. Compared to survival rationality and social rationality, economic rationality showed a lower association with patients’ choice to attend PCIs. Medical institutions are recommended to adopt a “patient health-centered” approach when providing medical services and further optimize the family doctor contracting system and construction of medical alliances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Office, Shenzhen Traditional Chinese Medicine Hospital, Guangdong, 518033, China.
- School of Public Health, Capital Medical University, Beijing, 100069, China.
- Medical Department, Shaanxi Provincial People's Hospital, Shaanxi, 710068, China.
ORCID-Profile: Jin Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Zhao, N., Gu, M., Li, D., & Yang, J. (2024). A study of patients' choice of medical treatment based on rational choice theory: a cross-sectional survey from China. Family Practice. https://doi.org/10.1093/fampra/cmae039
Vancouver
Li J, Zhao N, Gu M, Li D, Yang J. A study of patients' choice of medical treatment based on rational choice theory: a cross-sectional survey from China. Family Practice. 2024. doi:10.1093/fampra/cmae039
BibTeX
@article{Li2024,
author = {Li, Jin and Zhao, Ning and Gu, Mei and Li, Danhui and Yang, Jia},
title = {A study of patients' choice of medical treatment based on rational choice theory: a cross-sectional survey from China},
journal = {Family Practice},
year = {2024},
doi = {10.1093/fampra/cmae039}
}
EUVIMED